Vascular Endothelial Growth Factor Gene Polymorphism Is Associated With Long-term Kidney Allograft Outcomes

Area of Science:

• Genetics and Molecular Biology
• Immunology
• Nephrology

Background:

• Vascular endothelial growth factor (VEGF) is crucial for blood vessel formation in both normal and disease states.
• VEGF plays a role in physiological and pathological vasculogenesis.
• The study investigates the impact of specific VEGF gene variations on kidney transplant outcomes.

Purpose of the Study:

• To examine the association between VEGF single-nucleotide polymorphisms (SNPs) and chronic allograft nephropathy.
• To determine the influence of VEGF SNPs on kidney allograft survival rates.
• To identify specific VEGF genotypes that may predict graft loss or prolonged survival.

Main Methods:

• Genotyping of four VEGF SNPs (-1154 G/A, -2578 C/A, +936 C/T, -2549 Ins/Del) was performed on DNA from kidney transplant recipients.
• VEGF-A mRNA expression was quantified using the 2^-ΔΔCt method.
• Allograft survival was analyzed using Kaplan-Meier curves and log-rank tests, comparing outcomes across different VEGF genotypes.

Main Results:

• The AA and CA genotypes of the VEGF -2578 C/A SNP were significantly associated with an increased risk of graft loss.
• Adjusted analyses confirmed significant associations between VEGF SNPs (-2578 C/A and -2549 Ins/Del) and graft failure.
• The CC genotype of VEGF -2578 C/A, along with -1154*GG and +936*CC genotypes, demonstrated a protective effect, correlating with prolonged graft survival.

Conclusions:

• Kidney allograft recipients with VEGF genotypes associated with lower VEGF production experience shorter graft survival.
• Specific VEGF SNPs, particularly at the -2578 locus, are significant predictors of kidney allograft outcomes.
• Identifying these genetic markers could potentially aid in predicting transplant success and guiding patient management.